Bryn Mawr Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Bryn Mawr Trust CO

$4.09 Billion
Q3 2025

A detailed history of Bryn Mawr Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 106 shares of REGN stock, worth $73,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106

Previous 420 74.76%

Holding current value

$73,511

Previous $236,000 75.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 20, 2025	SELL	$534.91 - $598.71 $167,961 - $187,994	-314 Reduced 74.76%	106 $59,000
Q3 2025 Oct 28, 2025	SELL	$534.91 - $598.71 $163,682 - $183,205	-306 Reduced 42.15%	420 $236,000
Q2 2025 Jul 28, 2025	SELL	$483.07 - $625.6 $243,950 - $315,928	-505 Reduced 41.02%	726 $381,000
Q1 2025 May 08, 2025	SELL	$634.14 - $744.83 $294,240 - $345,601	-464 Reduced 27.37%	1,231 $780,000
Q4 2024 Jan 28, 2025	SELL	$701.85 - $1046.91 $80,712 - $120,394	-115 Reduced 6.35%	1,695 $1.21 Million

Q3 2024 Nov 25, 2024	BUY	$1024.09 - $1201.76 $1.22 Million - $1.43 Million	1,193 Added 193.35%	1,810 $1.9 Million
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $8,832 - $10,711	-10 Reduced 1.59%	617 $648,000
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $7,221 - $7,946	-8 Reduced 1.26%	627 $603,000
Q3 2023 Nov 15, 2023	SELL	$692.45 - $844.37 $18,003 - $21,953	-26 Reduced 3.93%	635 $522,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $6,124 - $7,442	9 Added 1.38%	661 $543,000
Q2 2021 Jul 29, 2021	SELL	$472.8 - $558.54 $1,891 - $2,234	-4 Reduced 0.61%	652 $364,000
Q1 2021 Apr 23, 2021	SELL	$446.73 - $548.2 $181,819 - $223,117	-407 Reduced 38.29%	656 $310,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $508,432 - $646,282	1,063 New	1,063 $514,000

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Regeneron Pharmaceuticals, Inc. Transaction History